| 2011年
12月31日 | 2012年
12月31日 | 2017年
12月31日 | 2018年
12月31日 | 2019年
12月31日 | 2020年
12月31日 | 2021年
12月31日 | 2022年
12月31日 |
|---|
| Net (loss) income | -8,705,711 | -4,272,489 | -42,239,231 | -36,502,316 | -37,162,827 | 70 | -401,344,813 | -117,274,218 |
|---|
| Depreciation | 229,378 | 293,007 | 549,973 | 348,339 | 388,401 | 809,645 | 2 | 2 |
|---|
| Amortization of Debt Issuance Costs and Discounts | - | 91,493 | - | - | 4 | 7 | - | - |
|---|
| Amortization of discount on Series B preferred stock | - | - | - | - | - | 6 | - | - |
|---|
| Change in fair value of convertible notes and loss on conversion to common stock | - | - | - | - | - | - | - | -1,769,857 |
|---|
| Fair Value Adjustment of Warrants | - | - | - | - | - | 12 | - | - |
|---|
| Change in fair value of investment in LMC | - | - | - | - | - | 318 | -225,429,997 | - |
|---|
| Deferred revenue | - | - | - | - | -103,000 | - | - | 500,000 |
|---|
| Payments for Preferred Stock Dividends, Noncash | - | - | - | - | -1,166,771 | -1,491,860 | - | - |
|---|
| Gain on sale of property, plant & equipment | - | - | - | - | - | - | - | -379,406 |
|---|
| Interest on Convertible Note Paid in Common Stock | - | - | - | - | - | 2 | - | - |
|---|
| Stock-based compensation | 3 | 4 | 1 | 1 | 2 | 4 | 5 | 11 |
|---|
| Inventory Write-down | - | - | - | 2 | 694,448 | - | 99 | 18 |
|---|
| Tangible Asset Impairment Charges | - | - | - | - | - | - | 7 | - |
|---|
| Forgiveness of PPP Term Note | - | - | - | - | - | - | 1 | - |
|---|
| Deferred tax (benefit) expense | - | - | - | - | - | -21,833,930 | 22 | - |
|---|
| Noncash Lease Expense | - | - | - | - | - | - | - | 1 |
|---|
| Other non-cash items | - | - | - | - | - | - | -102,858 | -599,982 |
|---|
| Accounts receivable | 5,019 | -5,019 | 223,133 | -1,024,366 | -76,163 | - | -982,388 | 17 |
|---|
| Inventory | 122,000 | 41,002 | 2 | 399,774 | -41,022 | 14 | 70 | 17 |
|---|
| Prepaid expenses and other current assets | 51,210 | 13,025 | 196,971 | 1 | 4 | 28 | -4,489,362 | 10 |
|---|
| Other assets | - | - | - | - | - | - | 91,909 | 84,401 |
|---|
| Accounts payable and accrued liabilities | - | - | - | 2 | -3,502,682 | 5 | 12 | 34 |
|---|
| Warranty liability | - | - | - | - | - | - | - | -2,376,242 |
|---|
| Other long-term liabilities | - | - | - | - | - | 207,040 | -207,040 | - |
|---|
| Net cash used in operating activities | - | - | -38,662,541 | -21,754,133 | -36,871,677 | -70,278,949 | -132,577,103 | -94 |
|---|
| Capital expenditures | 362,834 | 376,650 | 143,355 | 23,222 | 2 | 6 | 5 | 17 |
|---|
| Investment in Tropos | - | - | - | - | - | - | - | 5 |
|---|
| Proceeds from sale of fixed assets | 32,900 | 38,900 | - | 4,800 | 5,000 | - | - | 2 |
|---|
| Proceeds from sale of Investment in LMC | - | - | - | - | - | - | 105 | - |
|---|
| Net cash (used in) provided by investing activities | - | - | -143,355 | -18,422 | 2 | -5,728,130 | 100 | -20,019,519 |
|---|
| Proceeds from Convertible Debt | - | 2 | - | - | 39 | 262 | - | - |
|---|
| Proceeds from issuance of common stock | - | - | - | - | - | - | - | 13 |
|---|
| Exercise of warrants and options and restricted share award activity | - | - | - | - | - | - | -4,429,163 | -559,637 |
|---|
| Other | - | - | - | - | -1,340,700 | - | -2,387,956 | -857,516 |
|---|
| Net cash provided by (used in) financing activities | - | - | 42 | 19 | 59 | 292 | -6,817,119 | 11 |
|---|
| Change in cash, cash equivalents and restricted cash | - | - | - | - | 23 | 216 | -39,581,673 | -102,371,093 |
|---|
| Noncash or Part Noncash Acquisition, Investments Acquired | - | - | - | - | - | - | - | 5 |
|---|
| Fee paid to service partners in common stock | - | - | - | - | - | - | - | 599,891 |
|---|